ENROFLOXACIN KRKA 100 MG/ML ORAL SOLUTION FOR CHICKENS AND TURKEYS

Nazione: Irlanda

Lingua: inglese

Fonte: HPRA (Health Products Regulatory Authority)

Principio attivo:

ENROFLOXACIN

Commercializzato da:

Krka, d.d., Novo mesto

Codice ATC:

QJ01MA90

INN (Nome Internazionale):

ENROFLOXACIN

Dosaggio:

100 Mg/Ml

Forma farmaceutica:

Infus/Pdr/Oral Soln

Tipo di ricetta:

POM

Gruppo terapeutico:

Fowl - Chicken, Fowl - Turkey

Area terapeutica:

Enrofloxacin

Indicazioni terapeutiche:

Antibacterial

Stato dell'autorizzazione:

Authorised

Data dell'autorizzazione:

2013-06-14

Scheda tecnica

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Enrofloxacin Krka 100 mg/ml oral solution for chickens and turkeys.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml of oral solution contains:
ACTIVE SUBSTANCE:
Enrofloxacin 100 mg
EXCIPIENTS:
Benzyl alcohol 14 mg
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Oral solution.
Clear, yellow solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Chicken and Turkey.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of infections caused by the following bacteria susceptible to enrofloxacin:
Chickens
_Mycoplasma gallisepticum,_
_Mycoplasma synoviae,_
_Avibacterium paragallinarum,_
_Pasteurella multocida,_
_Escherichia coli._
Turkey
_Mycoplasma gallisepticum,_
_Mycoplasma synoviae,_
_Pasteurella multocida,_
_Escherichia coli._
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 11/05/2015_
_CRN 7020381_
_page number: 1_
4.3 CONTRAINDICATIONS
Do not use for prophylaxis.
Do not use when resistance / cross-resistance to (fluoro)quinolones is known to occur in the flock intended for
treatment.
Do not use in case of hypersensitivity to the active substance, other (fluoro)quinolones or to
any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Treatment of _Mycoplasma _spp. infections may not eradicate the organism.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Official and local antimicrobial policies should be taken into account when the product is used. Fluoroquinolones
should be reserved for the treatment of clinical conditions which have responded poorly, or are expected to respond
poorly, to other classes of antimicrobials.
Whenever possible, fluoroquinoones should only be u